Clinical Trial Update: Safety and Efficacy of Topically Applied CTA018 in Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of topically applied CTA018 in plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• CTA018

Snippet

Sponsor: OPKO Health, Inc. | Conditions: Psoriasis | Phase 2 | Status: COMPLETED